Pramipexole EP Impurity C
| CAT. No. | CP-P21003 |
|---|---|
| CAS. No. | 1973461-14-1 |
| Mol. F. | C20H32N6S2 |
| Mol. Wt. | 420.64 |
| Stock Status | Custom Synthesis |
VIEW COA- Category: Impurity Standards
- Synonyms: Pramipexole C-C Dimer
- Chemical Name: Mixture of diastereoisomers of (6S)-6-N-[3-[[(6S)-2-amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]amino]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
FAQ
Pramipexole EP Impurity C is an impurity that may form in Pramipexole formulations due to specific synthesis or storage conditions.
Monitoring this impurity is essential to ensure the safety and efficacy of Pramipexole formulations, as required by regulatory bodies.
It forms under specific synthesis or storage conditions that can lead to impurity development in Pramipexole.
Proper storage and careful control of synthesis conditions help minimize its formation.
Advanced techniques like GC-MS, LC-MS, and HPLC-MS are employed for accurate detection.
Chemicea supplies COA, H-NMR, MASS, HPLC, and TGA reports, with additional documentation available upon request.
Yes, Chemicea’s documentation meets the standards required by USFDA, EMA, ANVISA, PMDA, and others.
It is stable for shipping at room temperature, with specific storage conditions provided in the COA.
Yes, Chemicea offers both standard and customized pack sizes based on client requirements.
Chemicea provides this impurity as a reference standard to support regulatory compliance and quality control.
